# US 12,214,181 B1 · Systems, methods, and apparatus for administering drugs via implanted access port > Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt - Number: US 12,214,181 B1 - Document ID: US12214181B1 - Status: Granted - Kind: B1 - Application number: 18/587,365 - Filed: 2024-02-26 - Granted: 2025-02-04 - Earliest claimed: 2023-02-24 - Assignees: Matchstick LLC - Applicants: Matchstick LLC - Inventors: Christopher James Franzese; Martin Michael Coyne, III; Alejandra Linares Martinez; Matthew Conner D'Auria - Web page: https://patentgrep.com/patent/US12214181B1 ## CPC - A61B 5/06: Devices, other than using radiation, for detecting or locating foreign bodies {; Determining position of diagnostic devices within or on the body of the patient} - A61M 5/427: {Locating point where body is to be pierced, e.g. vein location means using ultrasonic waves, injection site templates} - A61M 5/20: Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically (A61M5/142 takes precedence) - A61M 39/0208: {Subcutaneous access sites (implantable infusion devices A61M5/14276; transcutaneous access sites A61M39/0247)} - A61M 39/0247: {Transcutaneous or percutaneous access sites to the inside of the body} - A61M 39/04: having pierceable self-sealing members - A61M 2039/0036: {characterised by a septum having particular features, e.g. having venting channels or being made from antimicrobial or self-lubricating elastomer} - A61M 2039/0205: {for injecting media} - A61M 2039/0238: {having means for locating the implanted device to insure proper injection, e.g. radio-emitter, protuberances, radio-opaque markers} - A61M 2039/0261: {Means for anchoring port to the body, or ports having a special shape or being made of a specific material to allow easy implantation/integration in the body} - A61M 2039/0267: {comprising sensors or electrical contacts} - A61M 2039/027: {having a particular valve, seal or septum} - A61M 2205/0216: Materials providing elastic properties, e.g. for facilitating deformation and avoid breaking - A61M 2205/04: implanted - A61M 2205/3303: Using a biosensor - A61M 2205/3306: Optical measuring means - A61M 2205/3317: Electromagnetic, inductive or dielectric measuring means - A61M 2205/3327: Measuring - A61M 2205/3375: Acoustical, e.g. ultrasonic, measuring means - A61M 2205/3553: remote, e.g. between patient's home and doctor's office - A61M 2205/3561: local, e.g. within room or hospital - A61M 2205/3584: using modem, internet or Bluetooth® - A61M 2205/505: Touch-screens; Virtual keyboard or keypads; Virtual buttons; Soft keys; Mouse touches - A61M 2205/581: by audible feedback - A61M 2205/582: by tactile feedback - A61M 2205/583: by visual feedback - A61M 2207/00: Methods of manufacture, assembly or production - A61M 2230/005: Parameter used as control input for the apparatus - A61M 2230/50: Temperature - A61M 2230/65: Impedance, e.g. conductivity, capacity - A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D) - A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)} ## Abstract A method for administering at least one drug to a patient includes determining, with a locator assembly of an apparatus, a location of an access port under a skin of the patient. The method further includes adhering a base plate of the apparatus to the skin of the patient at a location corresponding to the location of the access port, detaching the locator assembly from a base coupler of the base plate adhered to the skin, and administering, through an opening in the base plate adhered to the skin, a first drug to the patient. ## Claims ### Claim 1 A method for administering at least one drug to a patient, comprising: determining, with a locator assembly of an apparatus, a location of an access port under a skin of the patient; adhering a base plate of the apparatus to the skin of the patient at a location corresponding to the location of the access port; detaching the locator assembly from a base coupler of the base plate adhered to the skin; and administering, through an opening in the base plate adhered to the skin, a first drug to the patient. ### Claim 2 (depends on 1) The method of claim 1, wherein the administering the first drug to the patient further comprises: attaching a medication administration device to the base coupler, wherein the medication administration device includes a buttress structured to protrude within the opening in the base plate and restrict detachment of the medication administration device from the base coupler. ### Claim 3 (depends on 1) The method of claim 1, wherein the administering the first drug to the patient further comprises: attaching an autoinjector guide to the base coupler; and using an autoinjector with the autoinjector guide to administer the first drug to the patient through the opening in the base plate. ### Claim 4 (depends on 3) The method of claim 3, further comprising: prior to the using the autoinjector, replacing a needle of a syringe with an autoinjector needle to form the autoinjector. ### Claim 5 (depends on 1) The method of claim 1, wherein the administering the first drug to the patient further comprises: attaching an injection needle assembly to the base coupler; and using the injection needle assembly to puncture, via the opening, the skin of the patient and pierce an elastomeric septum of the access port to thereby place the injection needle assembly in fluidic coupling with the access port and administer the first drug to the patient therethrough. ### Claim 6 (depends on 1) The method of claim 1, wherein the administering the first drug to the patient further comprises: attaching a wearable injector to the base coupler; and causing protrusion of a needle of the wearable injector to puncture, via the opening, the skin of the patient and pierce an elastomeric septum of the access port to thereby place the wearable injector in fluidic coupling with the access port and administer the first drug to the patient therethrough. ### Claim 7 (depends on 1) The method of claim 1, further comprising: adhering a second base plate to the skin of the patient at a location adjacent to the location of the first base plate; and administering, through an opening in the second base plate, a second drug to the patient. ### Claim 8 (depends on 1) The method of claim 1, further comprising: prior to administering the first drug to the patient, sterilizing the skin of the patient exposed by the opening of the base plate with a sterilizing swab. ### Claim 9 A method for administering drugs to a patient, comprising: determining a location of an access port under a skin of the patient; adhering a base plate to the skin of the patient at a location corresponding to the location of the access port; administering a first drug to the patient including attaching a first medication administration device to the base plate adhered to the skin of the patient; removing the first medication administration device from the base plate; administering a second drug to the patient including attaching a second medication administration device to the base plate adhered to the skin of the patient; removing the second medication administration device from the base plate; administering a third drug to the patient including attaching a third medication administration device to the base plate adhered to the skin of the patient; and removing the third medication administration device from the base plate, wherein the base plate includes an adhesive flange and a base coupler on the adhesive flange. ### Claim 10 (depends on 9) The method of claim 9, wherein the first, second, and third medication administration devices are different types of medication administration devices. ### Claim 11 (depends on 9) The method of claim 9, wherein at least one of the first, second, or third medication administration devices is attached to the base coupler of the base plate, and another at least one of the first, second, or third medication administration devices is attached to a second base coupler of the base plate. ### Claim 12 (depends on 9) The method of claim 9, further comprising: administering a fourth drug to the patient including attaching a fourth medication administration device to a second base plate adhered to the skin of the patient, wherein the second base plate is adjacent to the base plate on the skin of the patient. ### Claim 13 (depends on 9) The method of claim 9, wherein each of the first, second, and third medication administration devices is a same type of medication administration device. ### Claim 14 (depends on 13) The method of claim 13, wherein the same type of medication administration device is at least one of an autoinjector, an injection needle assembly, or a wearable injector. ### Claim 15 (depends on 9) The method of claim 9, wherein the first, second, and third drugs comprise a regimen for treating a condition of the patient. ### Claim 16 (depends on 9) The method of claim 9, wherein the base plate includes an opening extending through the adhesive flange and the base coupler, and at least one of the first, second, or third drugs is administered to the patient via the opening. ### Claim 17 (depends on 9) The method of claim 9, wherein at least one of the first, second, or third drugs is administered to the patient subcutaneously.